Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $2,570 | 3 | 91.2% |
| Education | $146.90 | 2 | 5.2% |
| Food and Beverage | $102.33 | 5 | 3.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $1,420 | 2 | $0 (2023) |
| Alkermes, Inc. | $1,279 | 3 | $0 (2024) |
| ITI, Inc. | $46.91 | 1 | $0 (2021) |
| Indivior Inc. | $33.77 | 2 | $0 (2024) |
| ABBVIE INC. | $22.40 | 1 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $16.84 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $102.33 | 5 | Indivior Inc. ($33.77) |
| 2023 | $99.99 | 1 | Janssen Pharmaceuticals, Inc ($99.99) |
| 2022 | $650.00 | 1 | Alkermes, Inc. ($650.00) |
| 2021 | $1,967 | 3 | Janssen Pharmaceuticals, Inc ($1,320) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | Otsuka Pharmaceutical Development & Commercialization, Inc. | ABILIFY ASIMTUFII (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: PSYCHIATRY | ||||||
| 07/03/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: BH | ||||||
| 05/23/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: CNS | ||||||
| 04/11/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: BH | ||||||
| 02/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.40 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2023 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Neuroscience | ||||||
| 04/19/2022 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 10/18/2021 | Alkermes, Inc. | — | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| 05/17/2021 | ITI, Inc. | CAPLYTA (Drug) | Education | In-kind items and services | $46.91 | General |
| Category: PSYCHIATRY | ||||||
| 04/19/2021 | Janssen Pharmaceuticals, Inc | INVEGA (Drug) | Consulting Fee | Cash or cash equivalent | $1,320.00 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 108 | 700 | $113,950 | $60,068 |
| 2022 | 4 | 177 | 784 | $127,275 | $66,793 |
| 2021 | 2 | 137 | 827 | $131,980 | $73,846 |
| 2020 | 2 | 176 | 789 | $124,170 | $58,075 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 89 | 670 | $107,200 | $56,438 | 52.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 19 | 30 | $6,750 | $3,630 | 53.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 102 | 672 | $107,520 | $57,374 | 53.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 36 | 45 | $10,125 | $5,794 | 57.2% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 24 | 49 | $8,820 | $3,190 | 36.2% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 15 | 18 | $810.00 | $435.17 | 53.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 92 | 688 | $106,960 | $63,710 | 59.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 45 | 139 | $25,020 | $10,136 | 40.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 108 | 510 | $73,950 | $35,181 | 47.6% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 68 | 279 | $50,220 | $22,894 | 45.6% |
About Sarah Maclaurin, PMHNP
Sarah Maclaurin, PMHNP is a Nurse Practitioner healthcare provider based in Boston, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1104057918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Sarah Maclaurin, PMHNP has received a total of $2,819 in payments from pharmaceutical and medical device companies, with $102.33 received in 2024. These payments were reported across 10 transactions from 6 companies. The most common payment nature is "Consulting Fee" ($2,570).
As a Medicare-enrolled provider, Maclaurin has provided services to 598 Medicare beneficiaries, totaling 3,100 services with total Medicare billing of $258,783. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Psychiatric/Mental Health
- Location Boston, MA
- Active Since 07/29/2009
- Last Updated 09/08/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1104057918
Products in Payments
- INVEGA (Drug) $1,320
- INVEGA SUSTENNA (Drug) $99.99
- CAPLYTA (Drug) $46.91
- PERSERIS (Drug) $33.77
- VIVITROL (Drug) $29.32
- VRAYLAR (Drug) $22.40
- ABILIFY ASIMTUFII (Drug) $16.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Boston
Ms. Pamela Calarese, Rn Np, RN NP
Nurse Practitioner — Payments: $99,590
Teresa Fogaren, Agnp-C, AGNP-C
Nurse Practitioner — Payments: $86,708
Lauren Burke
Nurse Practitioner — Payments: $25,208
Ashley Hilmes, Np, NP
Nurse Practitioner — Payments: $15,134
Mrs. Kelly Goodwin, Aprn, APRN
Nurse Practitioner — Payments: $13,610
Rebecca Rathburn, Aprn, APRN
Nurse Practitioner — Payments: $13,521